Why integrated drug–device testing is critical in autoinjector development

Published: 8-Jul-2025 Featured companies: Solvias AG
Manufacturing Regulatory Drug Delivery

A guide to robust testing strategies for accelerating timelines and reducing regulatory risk

With rising biologic complexity and stricter regulations, robust testing in autoinjector development is essential. Download the white paper for a comprehensive guide to functional, E&L, CCIT and stability testing in NIS-AUTO – designed to accelerate timelines and mitigate regulatory risks.

Access the white paper

Featured companies

Solvias helps innovative companies advance their path to commercialization with CMC analytical solutions powered by deep scientific expertise and a relentless focus on our...
  • Companies:
  • Solvias AG
See more

You may also like

Manufacturing

Five trends on Solvias’ radar at CPHI Frankfurt 2025

Read more
The Solvias team shares its perspective on the scientific and regulatory shifts expected to be front and centre at this year’s event

Trending Articles

  1. Thermo Fisher Scientific highlights its new accelerator drug development solutions at CPHI Frankfurt 2025 The company has also announced a collaboration with OpenAI as well as a new digital toolbox, OSDPredict, which combines AI and machine learning models to predict formulation behaviour in small-molecule development
  2. Merck Life Science announces closure of Arklow facility Merck has said it will close the plant in Co Wicklow, Ireland, by the end of 2028, with the loss of 100 jobs
  3. Aseptic spray drying: Transforming biotherapeutics for a new era With interest in aseptic spray drying on the rise in the pharmaceutical industry, Dr Kevin Robinson spoke to GEA’s David Costes about how the company is combining process, engineering and technological expertise with market insights to provide a safe, reliable and high-performance technology for advanced biotherapeutic powder applications
  4. What to expect from a regulatory inspection NSF’s expert guide outlines key expectations, common pitfalls and strategies for lasting inspection readiness
  5. Hovione completes $100m investment cycle for expansion of US manufacturing campus The investment into the New Jersey facility will more than double capacity for spray drying

Relevant companies

See more

You may also like

Manufacturing

Five trends on Solvias’ radar at CPHI Frankfurt 2025

The Solvias team shares its perspective on the scientific and regulatory shifts expected to be front and centre at this year’s event
Manufacturing

Quality control: the central pillar supporting peptide manufacturing

Amid the growing complexity and innovation in the field, this article explores how centralised quality control plays a pivotal role by ensuring both safety and consistency during custom peptide production
Manufacturing

Solvias expands US biologics capabilities with cGMP-ready RTP facility

Milestone supports advanced therapies from early development to commercial release
Manufacturing

CMC Issues are a Leading Cause of Cell & Gene Therapies Clinical Holds

Overcoming CMC challenges to accelerate cell and gene therapy approvals
Manufacturing

Did you know? USP compliance is expected by 2026

Ensuring compliance and safety in single-use manufacturing
Manufacturing

Solvias to build Biologics and Cell & Gene Therapy testing centre in Research Triangle Park

Global provider continues to expand analytical service capabilities for life science companies developing advanced treatments for cancer and rare diseases
Manufacturing

Solvias to perform release testing on world’s first CRISPR-based gene-editing therapy

Global provider signs long-term agreement with Vertex Pharmaceuticals for CASGEVY (trademarked)
Subscribe now